Azevan Pharmaceuticals
is a drug development company... Read moreAzevan Pharmaceuticals
is a drug development company... Read more
CEO
Neal G. Simon
News
Sep 14, 2016
BioSpace
Azevan Pharmaceuticals: Azevan Pharmaceuticals Reports Positive Phase 2 Exploratory Clinical Study Results With SRX246 In Intermittent Explosive Disorder
May 09, 2016
BioSpace
Azevan Pharmaceuticals: <b>Azevan Pharmaceuticals</b> Completes Enrollment In Phase 2 Clinical Study Of SRX246 In Intermittent Explosive Disorder
May 08, 2016
PR Newswire
Press Release: Azevan Pharmaceuticals : Azevan Pharmaceuticals Completes Enrollment in Phase 2 Clinical Study of SRX246 in Intermittent Explosive Disorder
Apr 01, 2016
NewsMaker
Press Release: Azevan Pharmaceuticals :
Post-Traumatic Stress Disorder (PTSD) Therapeutics & Drugs Pipeline Review, H1 2016
Sep 04, 2015
BUSINESS WIRE
Press Release: Azevan Pharmaceuticals : Research and Markets: Premenstrual Syndrome Pipeline Review, H2 2015 - 5 Companies & 7 Drug Profiles
Aug 06, 2015
BUSINESS WIRE
Press Release: Azevan Pharmaceuticals : Research and Markets: Premenstrual Dysphoric Disorder (PMDD) - Pipeline Review, H1 2015
Jun 01, 2015
PR-INSIDE.COM
Press Release: Azevan Pharmaceuticals : Azevan Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - New Market Report
May 14, 2015
PR-INSIDE.COM
Press Release: Azevan Pharmaceuticals : "Azevan Pharmaceuticals, Inc. - Product Pipeline Review - 2015" Published
Feb 24, 2015
BUSINESS WIRE
Press Release: Azevan Pharmaceuticals : Research and Markets: Post-Traumatic Stress Disorder (PTSD) Therapeutics Pipeline Review, H1 2015 - Analysis of 15 Companies & 28 Drug Profiles
Dec 11, 2014
BUSINESS WIRE
Press Release: Azevan Pharmaceuticals : Research and Markets: Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2014
Azevan Pharmaceuticals Competitors
1
2
3
4
5
6
7
8
9
10